Japan Scrambles to Collect Info on AstraZeneca Vaccine Trial Pause, Sticks to 2021 H1 Immunization Goal

September 10, 2020
The Japanese government on September 9 scrambled to glean information on AstraZeneca’s voluntary trial pause on its COVID-19 vaccine, AZD1222, after it was revealed that all related studies were halted due to an “unexplained illness” that occurred in one subject...read more